| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.1 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |